Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 6,280 | 6,864 | 6,927 | 6,057 | 6,085 |
| Operating Income | -6,280 | -6,864 | -6,927 | -6,057 | -6,085 |
| Other Income | 27 | 0 | 13 | 5 | 8,191 |
| Pre-tax Income | -6,253 | -6,864 | -6,914 | -6,052 | 2,106 |
| Net Income Continuous | -6,253 | -6,864 | -6,914 | -6,052 | 2,106 |
| Net Income | $-6,253 | $-6,864 | $-6,914 | $-6,052 | $2,106 |
| EPS Basic Total Ops | -54.58 | -62.98 | -68.58 | -60.18 | 20.99 |
| EPS Basic Continuous Ops | -54.64 | -63.25 | -68.20 | -59.75 | 20.83 |
| EPS Diluted Total Ops | -54.58 | -62.98 | -68.58 | -60.18 | 20.99 |
| EPS Diluted Continuous Ops | -54.64 | -62.97 | -68.20 | -59.75 | 20.55 |
| EBITDA(a) | $-6,268 | $-6,853 | $-6,919 | $-6,052 | $-6,081 |